Christopher R. Drewry is an associate based in the Chicago office of Latham & Watkins and is a member of the firm’s Corporate Department. His practice includes representing private equity firms, corporations and investment banks in public and private mergers and acquisitions, corporate governance, takeover defense counseling and joint ventures. Representative clients include Energy Capital Partners, American Airlines, Leap Wireless and UBS Investment Bank.
Mr. Drewry has co-authored a series of articles on shareholder rights plans analyzing new poison pill technologies developed to address evolving threats to corporations and in response to the first triggering of a modern poison pill:
- The Resurgent Rights Plan: Recent Poison Pill Developments and Trends
- M&A Commentary—Implications for the Next Generation of Poison Pills
- M&A Commentary—Lessons from the First Triggering of a Modern Poison Pill
Mr. Drewry is a member of the American Bar Association, its Section of Business Law, the Illinois State Bar Association and the Chicago Bar Association. He is admitted to practice in the state of Illinois.
An avid traveler, Mr. Drewry has visited forty-eight states and over twenty-five countries.